Daniel Moldaver

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada

Dylan E. O’Sullivan, Winson Y. Cheung, Iqra Syed et al. · Current Oncology · 2021 · 36 citations · Full text

Medicine, Oncology, Chemotherapy +14

1165P Modelling long-term survival outcomes in patients with stage (stg) IB–IIIA EGFR-mutated NSCLC from the ADAURA trial

Parneet Cheema, B. Heeg, M Dyer et al. · Annals of Oncology · 2021 · 17 citations

Medicine, Oncology, Molecular Oncology +14

A cross-sectional evaluation of the idiopathic pulmonary fibrosis patient satisfaction and quality of life with a care coordinator

Nathan Hambly, Sarah Goodwin, Afia Aziz-Ur-Rehman et al. · Journal of Thoracic Disease · 2019 · 16 citations · Full text

Pharmacy, Internal Medicine, Cost-effectiveness Analysis +16

EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada

M. Sara Kuruvilla, Geoffrey Liu, Iqra Syed et al. · Lung Cancer · 2022 · 16 citations

Medicine, Oncology, Molecular Oncology +10

Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer

Andre Verhoek, Parneet Cheema, Barbara Melosky et al. · PharmacoEconomics - Open · 2023 · 16 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17